Form 8-K - Current report:
SEC Accession No. 0001193125-24-217333
Filing Date
2024-09-12
Accepted
2024-09-11 18:02:54
Documents
16
Period of Report
2024-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d865048d8k.htm   iXBRL 8-K 29055
2 EX-1.1 d865048dex11.htm EX-1.1 167135
3 EX-5.1 d865048dex51.htm EX-5.1 8162
7 GRAPHIC g865048g57d67.jpg GRAPHIC 3823
  Complete submission text file 0001193125-24-217333.txt   378238

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ions-20240909.xsd EX-101.SCH 2508
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240909_lab.xml EX-101.LAB 17203
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240909_pre.xml EX-101.PRE 10787
18 EXTRACTED XBRL INSTANCE DOCUMENT d865048d8k_htm.xml XML 3583
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 241293468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)